FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

John-Bjarne Hansen

Research Profile

Chemicals & Drugs

Concepts & Ideas

Disorders

Co-author Network

Publications

TOP 3
Erin M Hald; Sigrid K Brækkan; Ellen E Brodin; Anders Vik; John-Bjarne Hansen
Postprandial lipemia is not increased in patients with previous unprovoked venous thromboembolism.
Audhild Nyrnes; Tove Skjelbakken; Tom Wilsgaard; John-Bjarne Hansen; Lone Jørgensen; Ellisiv B Mathiesen; Inger Njølstad; Maja-Lisa Løchen
Inflammatory biomarkers as risk factors for future atrial fibrillation. An eleven-year follow-up of 6315 men and women: the Tromsø study.
Bakhtawar K Mahmoodi; Kunihiro Matsushita; Karina Meijer; Inger Anne Naess; Yingying Sang; Nic J G M Veeger; Brad C Astor; Sigrid K Brækkan; Ellen E Brodin; Suzanne C Cannegieter; Josef Coresh; Aaron R Folsom; Ron T Gansevoort; Stein I Hallan; Jens Hammerstrøm; John-Bjarne Hansen; Pamela L Lutsey; Mary Cushman
Association of mild to moderate chronic kidney disease with venous thromboembolism: pooled analysis of five prospective general population cohorts.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of John-Bjarne Hansen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Erin M Hald; Sigrid K Brækkan; Ellen E Brodin; Anders Vik; John-Bjarne Hansen
Postprandial lipemia is not increased in patients with previous unprovoked venous thromboembolism.
Journal of clinical lipidology 2013;7(1):48-55.
2012: Audhild Nyrnes; Tove Skjelbakken; Tom Wilsgaard; John-Bjarne Hansen; Lone Jørgensen; Ellisiv B Mathiesen; Inger Njølstad; Maja-Lisa Løchen
Inflammatory biomarkers as risk factors for future atrial fibrillation. An eleven-year follow-up of 6315 men and women: the Tromsø study.
Gender medicine 2012;9(6):536-547.e2.
2012: Bakhtawar K Mahmoodi; Kunihiro Matsushita; Karina Meijer; Inger Anne Naess; Yingying Sang; Nic J G M Veeger; Brad C Astor; Sigrid K Brækkan; Ellen E Brodin; Suzanne C Cannegieter; Josef Coresh; Aaron R Folsom; Ron T Gansevoort; Stein I Hallan; Jens Hammerstrøm; John-Bjarne Hansen; Pamela L Lutsey; Mary Cushman
Association of mild to moderate chronic kidney disease with venous thromboembolism: pooled analysis of five prospective general population cohorts.
Circulation 2012;126(16):1964-71.
2012: Anders Vik; Sigrid K Brækkan; Ellen Brodin; John-Bjarne Hansen
Serum osteoprotegerin and future risk of venous thromboembolism. The Tromsø study.
Thrombosis research 2012;130(4):e236-7.
2012: Manjunath Goolyam Basavaraj; Jan Ole Olsen; Bjarne Osterud; John-Bjarne Hansen
Differential ability of tissue factor antibody clones on detection of tissue factor in blood cells and microparticles.
Thrombosis research 2012;130(3):538-46.
2012: Lone Jørgensen; Ellisiv Mathiesen; Jan Størmer; Anders Vik; Luai Ahmed; Ashild Bjørnerem; Nina Emaus; John-Bjarne Hansen; Ragnar M Joakimsen; Bjarne K Jacobsen
Osteoprotegerin is associated with hip fracture incidence: the Tromso Study.
International journal of epidemiology 2012;41(4):1033-9.
2012: Ellen E Brodin; Jan Brox; Sigrid K Brækkan; Anders Vik; John-Bjarne Hansen
Cystatin C is associated with risk of venous thromboembolism in subjects with normal kidney function--the Tromsø study.
Haematologica 2012;97(7):1008-13.
2012: Mikhail A Sovershaev; Bjarne Osterud; Elena M Egorina; John-Bjarne Hansen
Evidence for direct transfer of tissue factor from monocytes to platelets in whole blood.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2012;23(4):345-50.
2012: Anders Vik; Vidar Isaksen; Jan Brox; John-Bjarne Hansen
[Middle-aged female presenting with headache, blurred vision and skin rash].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2012;132(10):1246-8.
2012: Manjunath Goolyam Basavaraj; Vladimir Y Bogdanov; Elena M Egorina; John T Fallon; Franz X Gruber; Ellisiv B Mathiesen; Mikhail A Sovershaev; Bjarne Osterud; John-Bjarne Hansen
Circulating monocytes mirror the imbalance in TF and TFPI expression in carotid atherosclerotic plaques with lipid-rich and calcified morphology.
Thrombosis research 2012;129(4):e134-41.
2012: Elena M Egorina; John-Bjarne Hansen; T A Sovershaev; Mikhail A Sovershaev
BMP-2 inhibits TF expression in human monocytes by shutting down MAPK signaling and AP-1 transcriptional activity.
Thrombosis research 2012;129(4):e106-11.
2012: John-Bjarne Hansen; Knut H Borch; Jan H Brox; José A Fernández; John H Griffin; Sigrid K Braekkan
Activated protein C plasma levels in the fasting and postprandial states among patients with previous unprovoked venous thromboembolism.
Thrombosis research 2012;129(4):502-7.
2012: Sigrid K Brækkan; Erin M Hald; Ellisiv B Mathiesen; Inger Njølstad; Frits R Rosendaal; Tom Wilsgaard; John-Bjarne Hansen
Competing risk of atherosclerotic risk factors for arterial and venous thrombosis in a general population: the Tromso study.
Arteriosclerosis, thrombosis, and vascular biology 2012;32(2):487-91.
2011: Cristina Ionica Øie; Helle Heibroch Petersen; Bård Smedsrød; Rupa Shree Appa; Albrecht Gruhler; Ida Hilden; John-Bjarne Hansen
Rat liver sinusoidal endothelial cells (LSECs) express functional low density lipoprotein receptor-related protein-1 (LRP-1).
Journal of hepatology 2011;55(6):1346-52.
2011: Elena M Egorina; Mikhail A Sovershaev; John-Bjarne Hansen
The role of tissue factor in systemic inflammatory response syndrome.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2011;22(6):451-6.
2011: M G Basavaraj; S K Brækkan; E Brodin; Bjarne Osterud; John-Bjarne Hansen
Monocyte count and procoagulant functions are associated with risk of venous thromboembolism: the Tromsø study.
Journal of thrombosis and haemostasis : JTH 2011;9(8):1673-6.
2011: Ida J Hansen-Krone; Tom Wilsgaard; Sigrid K Brækkan; Kristin F Enga; John-Bjarne Hansen
Alcohol consumption, types of alcoholic beverages and risk of venous thromboembolism - the Tromsø Study.
Thrombosis and haemostasis 2011;106(2):272-8.
2011: Erin M Hald; Sigrid K Brækkan; Jan Brox; Ellisiv B Mathiesen; Inger Njølstad; Tom Wilsgaard; John-Bjarne Hansen
High-sensitivity C-reactive protein is not a risk factor for venous thromboembolism: the Tromso study.
Haematologica 2011;96(8):1189-94.
2011: Knut H Borch; Cecilie Nyegaard; John-Bjarne Hansen; Ellisiv B Mathiesen; Inger Njølstad; Tom Wilsgaard; Sigrid K Brækkan
Joint effects of obesity and body height on the risk of venous thromboembolism: the Tromsø Study.
Arteriosclerosis, thrombosis, and vascular biology 2011;31(6):1439-44.
2011: Lone Jørgensen; John-Bjarne Hansen; Jan Brox; Ellisiv B Mathiesen; Anders Vik; Bjarne K Jacobsen
Serum osteoprotegerin levels are related to height loss: the Tromsø Study.
European journal of epidemiology 2011;26(4):305-12.
2011: Ellen Brodin; Torkel Vikan; John-Bjarne Hansen; Johan Svartberg
Testosterone, hemostasis, and cardiovascular diseases in men.
Seminars in thrombosis and hemostasis 2011;37(1):87-94.
2011: John-Bjarne Hansen; Johan Björkegren; Hiroshi Deguchi; José A Fernández; Ann-Trude With Notø; Ellisiv B Mathiesen
The apolipoprotein C-I content of very-low-density lipoproteins is associated with fasting triglycerides, postprandial lipemia, and carotid atherosclerosis.
Journal of lipids 2011;2011():271062.
2010: Knut H Borch; Ida Hansen-Krone; Sigrid K Braekkan; Ellisiv B Mathiesen; Inger Njolstad; Tom Wilsgaard; John-Bjarne Hansen
Physical activity and risk of venous thromboembolism. The Tromso study.
Haematologica 2010;95(12):2088-94.
2010: Manjunath Goolyam Basavaraj; Franz X Gruber; Mikhail A Sovershaev; Hege I Appelbom; Bjarne Osterud; Lars C Petersen; John-Bjarne Hansen
The role of TFPI in regulation of TF-induced thrombogenicity on the surface of human monocytes.
Thrombosis research 2010;126(5):418-25.
2010: Mikhail A Sovershaev; Elena M Egorina; V Y Bogdanov; N Seredkina; J T Fallon; A Y Valkov; B Østerud; John-Bjarne Hansen
Bone morphogenetic protein -7 increases thrombogenicity of lipid-rich atherosclerotic plaques via activation of tissue factor.
Thrombosis research 2010;126(4):306-10.
2010: Samira Lekhal; Trond Børvik; Ellen Brodin; Arne Nordøy; John-Bjarne Hansen
Tissue factor-induced thrombin generation in the fasting and postprandial state among elderly survivors of myocardial infarction.
Thrombosis research 2010;126(4):353-9.
2010: Sigrid K Braekkan; Knut H Borch; Ellisiv B Mathiesen; Inger Njølstad; Tom Wilsgaard; John-Bjarne Hansen
Body height and risk of venous thromboembolism: The Tromsø Study.
American journal of epidemiology 2010;171(10):1109-15.
2010: Rolf Jorde; Monica Sneve; Peter Torjesen; Yngve Figenschau; John-Bjarne Hansen
Parameters of the thrombogram are associated with serum 25-hydroxyvitamin D levels at baseline, but not affected during supplementation with vitamin D.
Thrombosis research 2010;125(5):e210-3.
2010: Sigrid K Braekkan; Ellisiv B Mathiesen; Inger Njølstad; Tom Wilsgaard; John-Bjarne Hansen
Hematocrit and risk of venous thromboembolism in a general population. The Tromso study.
Haematologica 2010;95(2):270-5.
2010: Rolf Jorde; Monica Sneve; Peter A Torjesen; Yngve Figenschau; John-Bjarne Hansen; Guri Grimnes
No significant effect on bone mineral density by high doses of vitamin D3 given to overweight subjects for one year.
Nutrition journal 2010;9():1.
2010: Knut H Borch; Sigrid K Braekkan; Ellisiv B Mathiesen; Inger Njølstad; Tom Wilsgaard; Jan Størmer; John-Bjarne Hansen
Anthropometric measures of obesity and risk of venous thromboembolism: the Tromso study.
Arteriosclerosis, thrombosis, and vascular biology 2010;30(1):121-7.
2009: Ingvild Agledahl; Ellen Brodin; Johan Svartberg; John-Bjarne Hansen
Impact of long-term testosterone treatment on plasma levels of free TFPI and TF-induced thrombin generation ex vivo in elderly men with low testosterone levels.
Thrombosis and haemostasis 2009;102(5):945-50.
2009: Mikhail A Sovershaev; Elena M Egorina; John-Bjarne Hansen; Bjarne Østerud; Pál Pacher; Johannes-Peter Stasch; Oleg V Evgenov
Soluble guanylate cyclase agonists inhibit expression and procoagulant activity of tissue factor.
Arteriosclerosis, thrombosis, and vascular biology 2009;29(10):1578-86.
2009: Anders Vik; Pål Andre Holme; Kulbir Singh; Eric Dorenberg; Kåre Christian Nordhus; Satish Kumar; John-Bjarne Hansen
Catheter-directed thrombolysis for treatment of deep venous thrombosis in the upper extremities.
Cardiovascular and interventional radiology 2009;32(5):980-7.
2009: Johan Svartberg; Sigrid K Braekkan; Gail A Laughlin; John-Bjarne Hansen
Endogenous sex hormone levels in men are not associated with risk of venous thromboembolism: the Tromso study.
European journal of endocrinology / European Federation of Endocrine Societies 2009;160(5):833-8.
2009: Annika E Michelsen; Ann-Trude Notø; Ellen Brodin; Ellisiv B Mathiesen; Frank Brosstad; John-Bjarne Hansen
Elevated levels of platelet microparticles in carotid atherosclerosis and during the postprandial state.
Thrombosis research 2009;123(6):881-6.
2009: Ingvild Agledahl; Ellen Brodin; Johan Svartberg; John-Bjarne Hansen
Plasma free tissue factor pathway inhibitor (TFPI) levels and TF-induced thrombin generation ex vivo in men with low testosterone levels.
Thrombosis and haemostasis 2009;101(3):471-7.
2009: Ellen Brodin; Hege Appelbom; Bjarne Osterud; Ida Hilden; Lars C Petersen; John-Bjarne Hansen
Regulation of thrombin generation by TFPI in plasma without and with heparin.
Translational research : the journal of laboratory and clinical medicine 2009;153(3):124-31.
2009: Steinar Hunskaar; Jarle Breivik; Maje Siebke; Karin Tømmerås; Kristian Figenschau; John-Bjarne Hansen
Evaluation of the medical student research programme in Norwegian medical schools. A survey of students and supervisors.
BMC medical education 2009;9():43.
2009: Anders Vik; Guanglin Cui; Vidar Isaksen; Trude Wik; John-Bjarne Hansen
Erythropoietin production by a hepatic adenoma in a patient with severe erythrocytosis.
Acta haematologica 2009;121(1):52-5.
2008: Samira Lekhal; Trond Børvik; Arne Nordøy; John-Bjarne Hansen
Decreased lipoprotein lipase activity and increased postprandial concentrations of triglyceride-rich lipoproteins in offspring of elderly survivors of myocardial infarction.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2008;18(10):700-6.
2008: S K Braekkan; E B Mathiesen; Inger Njølstad; Tom Wilsgaard; Jan Størmer; John-Bjarne Hansen
Family history of myocardial infarction is an independent risk factor for venous thromboembolism: the Tromsø study.
Journal of thrombosis and haemostasis : JTH 2008;6(11):1851-7.
2008: M A Sovershaev; K F Lind; H Devold; T Ø Jørgensen; John-Bjarne Hansen; B Østerud; E M Egorina
No evidence for the presence of tissue factor in high-purity preparations of immunologically isolated eosinophils.
Journal of thrombosis and haemostasis : JTH 2008;6(10):1742-9.
2008: Ann-Trude With Notø; Ellisiv Bøgeberg Mathiesen; Jan Brox; Johan Björkegren; John-Bjarne Hansen
The ApoC-I content of VLDL particles is associated with plaque size in persons with carotid atherosclerosis.
Lipids 2008;43(7):673-9.
2008: Samira Lekhal; Trond Børvik; Arne Nordøy; John-Bjarne Hansen
Increased postprandial triglyceride-rich lipoprotein levels in elderly survivors of myocardial infarction.
Lipids 2008;43(6):507-15.
2008: Ingvild Agledahl; Paal-André Skjaerpe; John-Bjarne Hansen; Johan Svartberg
Low serum testosterone in men is inversely associated with non-fasting serum triglycerides: the Tromsø study.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2008;18(4):256-62.
2008: Ann-Trude With Notø; Ellisiv Bøgeberg Mathiesen; Jan Brox; Johan Björkegren; John-Bjarne Hansen
Delayed metabolism of postprandial triglyceride-rich lipoproteins in subjects with echolucent carotid plaques.
Lipids 2008;43(4):353-60.
2008: Ann-Trude With Notø; Ellisiv Bøgeberg Mathiesen; Bjarne Østerud; Jean Amiral; Anne Marie Vissac; John-Bjarne Hansen
Increased thrombin generation in persons with echogenic carotid plaques.
Thrombosis and haemostasis 2008;99(3):602-8.
2008: Cristina Ionica Oie; Randi Olsen; Bård Smedsrød; John-Bjarne Hansen
Liver sinusoidal endothelial cells are the principal site for elimination of unfractionated heparin from the circulation.
American journal of physiology. Gastrointestinal and liver physiology 2008;294(2):G520-8.
2008: Ingvild Agledahl; John-Bjarne Hansen; Johan Svartberg
Impact of testosterone treatment on postprandial triglyceride metabolism in elderly men with subnormal testosterone levels.
Scandinavian journal of clinical and laboratory investigation 2008;68(7):641-8.
2008: Annika E Michelsen; Ellen Brodin; Frank Brosstad; John-Bjarne Hansen
Increased level of platelet microparticles in survivors of myocardial infarction.
Scandinavian journal of clinical and laboratory investigation 2008;68(5):386-92.
2007: Anders Vik; Ellen Brodin; Baldur Sveinbjørnsson; John-Bjarne Hansen
Heparin induces mobilization of osteoprotegerin into the circulation.
Thrombosis and haemostasis 2007;98(1):148-54.
2007: Sigrid Braekkan; Sameline Grimsgaard; John-Bjarne Hansen
[Thromboembolic prophylaxis in hospitalized medical patients].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2007;127(9):1177-80.
2007: Dag S Halvorsen; Joachim Karlsen; Ann-Trude W Notø; Ellisiv B Mathiesen; Inger Njølstad; Tore J Gutteberg; Lars H Vorland; John-Bjarne Hansen
No detectable Chlamydia pneumoniae and cytomegalovirus DNA in leukocytes in subjects with echolucent and echogenic carotid artery plaques.
International journal of cardiology 2007;117(3):388-94.
2007: Anders Vik; Ellisiv B Mathiesen; Ann-Trude W Notø; Baldur Sveinbjørnsson; Jan Brox; John-Bjarne Hansen
Serum osteoprotegerin is inversely associated with carotid plaque echogenicity in humans.
Atherosclerosis 2007;191(1):128-34.
2007: Rolf Jorde; Egil Haug; Yngve Figenschau; John-Bjarne Hansen
Serum levels of vitamin D and haemostatic factors in healthy subjects: the Tromsø study.
Acta haematologica 2007;117(2):91-7.
2006: Ann-Trude With Notø; Ellisiv Bøgeberg Mathiesen; Jean Amiral; Anne Marie Vissac; John-Bjarne Hansen
Endothelial dysfunction and systemic inflammation in persons with echolucent carotid plaques.
Thrombosis and haemostasis 2006;96(1):53-9.
2006: Anders Vik; Ellen Brodin; Trond Børvik; Baldur Sveinbjørnsson; John-Bjarne Hansen
Serum osteoprotegerin in young survivors of myocardial infarction.
Thrombosis and haemostasis 2006;95(5):881-5.
2006: Rolf Jorde; Yngve Figenschau; John-Bjarne Hansen
Haemostatic function in subjects with mild subclinical hypothyroidism. The Tromsø study.
Thrombosis and haemostasis 2006;95(4):750-1.
2006: Ellen Brodin; Nina Iversen; John-Bjarne Hansen
Impact of native VLDL on tissue factor pathway inhibitor in endothelial cells and interactions between TFPI and lipoprotein lipase.
The Journal of laboratory and clinical medicine 2006;147(4):167-73.
2005: Tor Melberg; Magne Thoresen; John-Bjarne Hansen; Arne Westheim
[How are patients with acute coronary syndromes treated in Norwegian hospitals?].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2005;125(21):2925-8.
2005: Anders Vik; Reidar Berntsen; Vidar Isaksen; Egil Haug; John-Bjarne Hansen
[A 53-year-old man with headache and concentration difficulties].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2005;125(19):2647-9.
2005: Ganesh Acharya; Kulbir Singh; John-Bjarne Hansen; Satish Kumar; Jan Martin Maltau
Catheter-directed thrombolysis for the management of postpartum deep venous thrombosis.
Acta obstetricia et gynecologica Scandinavica 2005;84(2):155-8.
2004: Ellen Brodin; Birgit Svensson; Ruth H Paulssen; Arne Nordoy; John-Bjarne Hansen
Intravascular release and urinary excretion of tissue factor pathway inhibitor during heparin treatment.
The Journal of laboratory and clinical medicine 2004;144(5):246-53; discussion 226-7.
2004: Ellen Brodin; Trond Børvik; Per Morten Sandset; Kaare H Bønaa; Arne Nordøy; John-Bjarne Hansen
Coagulation activation in young survivors of myocardial infarction (MI)--a population-based case-control study.
Thrombosis and haemostasis 2004;92(1):178-84.
2003: Anders Vik; Satish Kumar; Kulbir Singh; John-Bjarne Hansen
[Local thrombolysis with stent implantation in a patient with vena cava superior syndrome].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2003;123(15):2049-50.
2003: Arne Nordøy; B Svensson; John-Bjarne Hansen
Atorvastatin and omega-3 fatty acids protect against activation of the coagulation system in patients with combined hyperlipemia.
Journal of thrombosis and haemostasis : JTH 2003;1(4):690-7.
2002: Dag S Halvorsen; T Børvik; Inger Njølstad; Tore J Gutteberg; Lars H Vorland; John-Bjarne Hansen
Chlamydia pneumoniae IgA- and IgG antibodies in young survivors of myocardial infarction. A comparison of antibody detection by a microimmunofluorescence test and an enzyme immunoassay.
Journal of internal medicine 2002;251(2):142-7.
2001: R F Hallstensen; J Svartberg; V Isaksen; R Bajic; M L Løchen; John-Bjarne Hansen
[Anemia and neutropenia in primary empty sella syndrome].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2001;121(29):3391-4.
2001: G Thomassen; M S Hansen; A Nordøy; John-Bjarne Hansen
[Antithrombotic treatment of atrial fibrillation in hospital].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2001;121(24):2800-4.
2001: A T Notø; L Steffensen; A Nordøy; John-Bjarne Hansen
[Use of statins in hospitals after myocardial infarction].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2001;121(21):2467-71.
2001: John-Bjarne Hansen; Sameline Grimsgaard; Nils-Erik Huseby; Per Morten Sandset; Kaare H Bønaa
Serum lipids and regulation of tissue factor-induced coagulation in middle-aged men.
Thrombosis research 2001;102(1):3-13.
2001: Arne Nordøy; John-Bjarne Hansen; Jan Brox; B Svensson
Effects of atorvastatin and omega-3 fatty acids on LDL subfractions and postprandial hyperlipemia in patients with combined hyperlipemia.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2001;11(1):7-16.
2000: John-Bjarne Hansen; T Naalsund; Per Morten Sandset; B Svensson
Rebound activation of coagulation after treatment with unfractionated heparin and not with low molecular weight heparin is associated with partial depletion of tissue factor pathway inhibitor and antithrombin.
Thrombosis research 2000;100(5):413-7.
2000: John-Bjarne Hansen; B Svensson; Per Morten Sandset; F Thijssen
Reduction of factor FVIIa activity during heparin therapy. Evidence for assay interactions with tissue factor pathway inhibitor and antithrombin.
Thrombosis research 2000;100(5):389-96.
2000: John-Bjarne Hansen; B Svensson; Randi Olsen; M Ezban; Bjarne Osterud; Ruth H Paulssen
Heparin induces synthesis and secretion of tissue factor pathway inhibitor from endothelial cells in vitro.
Thrombosis and haemostasis 2000;83(6):937-43.
2000: Thomas Pernerstorfer; Ursula Hollenstein; John-Bjarne Hansen; PJ Stohlawetz; Hans-Georg Eichler; Sylvia Handler; Wolfgang Speiser; Bernd Jilma
Lepirudin blunts endotoxin-induced coagulation activation.
Blood 2000;95(5):1729-34.
2000: Arne Nordøy; Kaare H Bønaa; Per Morten Sandset; John-Bjarne Hansen; Heidi Nilsen
Relationship between apolipoprotein E polymorphism, postprandial hyperlipemia and hemostatic variables in patients with combined hyperlipemia.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2000;10(1):15-23.
2000: Per Morten Sandset; B Bendz; John-Bjarne Hansen
Physiological function of tissue factor pathway inhibitor and interaction with heparins.
Haemostasis 2000;30 Suppl 2():48-56.
2000: Arne Nordoy; KH Bonaa; Per Morten Sandset; John-Bjarne Hansen; Heidi Nilsen
Effect of omega-3 fatty acids and simvastatin on hemostatic risk factors and postprandial hyperlipemia in patients with combined hyperlipemia.
Arteriosclerosis, thrombosis, and vascular biology 2000;20(1):259-65.
1999: Bjørn Bendz; John-Bjarne Hansen; Trine Opstad Andersen; PB Ostergaard; Per Morten Sandset
Partial depletion of tissue factor pathway inhibitor during subcutaneous administration of unfractionated heparin, but not with two low molecular weight heparins.
British journal of haematology 1999;107(4):756-62.
1999: E Krefting; John-Bjarne Hansen; A Nordøy
[Use of statins following myocardial infarction before and after the 4S study].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1999;119(20):2986-9.
1999: Carina Seidel; Henrik Hjorth-Hansen; B Bendz; Magne Borset; P M Sandset; John-Bjarne Hansen; Anders Sundan; Anders Waage
Hepatocyte growth factor in serum after injection of unfractionated and low molecular weight heparin in healthy individuals.
British journal of haematology 1999;105(3):641-7.
1998: John-Bjarne Hansen; Rolf K Berge; Arne Nordøy; Kaare H Bønaa
Lipid peroxidation of isolated chylomicrons and oxidative status in plasma after intake of highly purified eicosapentaenoic or docosahexaenoic acids.
Lipids 1998;33(11):1123-9.
1998: John-Bjarne Hansen; Per Morten Sandset
Differential effects of low molecular weight heparin and unfractionated heparin on circulating levels of antithrombin and tissue factor pathway inhibitor (TFPI): a possible mechanism for difference in therapeutic efficacy.
Thrombosis research 1998;91(4):177-81.
1998: Sameline Grimsgaard; Kaare H Bønaa; John-Bjarne Hansen; Eivind S P Myhre
Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on hemodynamics in humans.
The American journal of clinical nutrition 1998;68(1):52-9.
1998: John-Bjarne Hansen; Per Morten Sandset; K R Huseby; Nils-Erik Huseby; Bjørn Bendz; PB Ostergaard; Arne Nordøy
Differential effect of unfractionated heparin and low molecular weight heparin on intravascular tissue factor pathway inhibitor: evidence for a difference in antithrombotic action.
British journal of haematology 1998;101(4):638-46.
1998: L Balteskard; K Unneberg; Dag S Halvorsen; John-Bjarne Hansen; Arthur Revhaug
Effects of insulin-like growth factor 1 on neutrophil and monocyte functions in normal and septic states.
JPEN. Journal of parenteral and enteral nutrition 1998;22(3):127-35.
1998: Arne Nordøy; Kaare H Bønaa; Heidi Nilsen; Rolf K Berge; John-Bjarne Hansen; Ole Christian Ingebretsen
Effects of Simvastatin and omega-3 fatty acids on plasma lipoproteins and lipid peroxidation in patients with combined hyperlipidaemia.
Journal of internal medicine 1998;243(2):163-70.
1998: John-Bjarne Hansen; Sameline Grimsgaard; Heidi Nilsen; Arne Nordøy; Kaare H Bønaa
Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on fatty acid absorption, incorporation into serum phospholipids and postprandial triglyceridemia.
Lipids 1998;33(2):131-8.
1997: John-Bjarne Hansen; Randi Olsen; P Webster
Association of tissue factor pathway inhibitor with human umbilical vein endothelial cells.
Blood 1997;90(9):3568-78.
1997: Dag S Halvorsen; John-Bjarne Hansen; Sameline Grimsgaard; Kaare H Bønaa; P Kierulf; Arne Nordøy
The effect of highly purified eicosapentaenoic and docosahexaenoic acids on monocyte phagocytosis in man.
Lipids 1997;32(9):935-42.
1997: PB Ostergaard; T C Beck; H Orsted; A Svendsen; O Nordfang; Per Morten Sandset; John-Bjarne Hansen
An enzyme linked immunosorption assay for tissue factor pathway inhibitor.
Thrombosis research 1997;87(5):447-59.
1997: Sameline Grimsgaard; KH Bonaa; John-Bjarne Hansen; Arne Nordøy
Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids.
The American journal of clinical nutrition 1997;66(3):649-59.
1997: John-Bjarne Hansen; K R Huseby; Nils-Erik Huseby; M Ezban; Arne Nordøy
Tissue factor pathway inhibitor in complex with low density lipoprotein isolated from human plasma does not possess anticoagulant function in tissue factor-induced coagulation in vitro.
Thrombosis research 1997;85(5):413-25.
1996: John-Bjarne Hansen; Per Morten Sandset; K R Huseby; Nils-Erik Huseby; Arne Nordøy
Depletion of intravascular pools of tissue factor pathway inhibitor (TFPI) during repeated or continuous intravenous infusion of heparin in man.
Thrombosis and haemostasis 1996;76(5):703-9.
1995: John-Bjarne Hansen; K R Huseby; Nils-Erik Huseby; Per Morten Sandset; T A Hanssen; Arne Nordøy
Effect of cholesterol lowering on intravascular pools of TFPI and its anticoagulant potential in type II hyperlipoproteinemia.
Arteriosclerosis, thrombosis, and vascular biology 1995;15(7):879-85.
1995: John-Bjarne Hansen; Dag S Halvorsen; B C Haldorsen; Randi Olsen; Haakon Sjursen; P Kierulf
Retention of phagocytic functions in cryopreserved human monocytes.
Journal of leukocyte biology 1995;57(2):235-41.
1994: John-Bjarne Hansen; B Svensson; C L Zhang; V Lyngmo; Arne Nordøy
Basal plasma concentration of tissue plasminogen activator (t-PA) and the adaption to strenuous exercise in familial hypercholesterolaemia (FH).
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1994;5(5):781-7.
1994: John-Bjarne Hansen; Nils-Erik Huseby; Per Morten Sandset; B Svensson; V Lyngmo; Arne Nordøy
Tissue-factor pathway inhibitor and lipoproteins. Evidence for association with and regulation by LDL in human plasma.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1994;14(2):223-9.
1994: Arne Nordøy; John-Bjarne Hansen
Omega 3 fatty acids and cardiovascular risk factors.
World review of nutrition and dietetics 1994;76():51-4.
1993: John-Bjarne Hansen; Jan Ole Olsen; L Wilsgård; V Lyngmo; B Svensson
Comparative effects of prolonged intake of highly purified fish oils as ethyl ester or triglyceride on lipids, haemostasis and platelet function in normolipaemic men.
European journal of clinical nutrition 1993;47(7):497-507.
1993: John-Bjarne Hansen; L N Berge; B Svensson; V Lyngmo; Arne Nordøy
Effects of cod liver oil on lipids and platelets in males and females.
European journal of clinical nutrition 1993;47(2):123-31.
1993: John-Bjarne Hansen; V Lyngmo; B Svensson; Arne Nordøy
Inhibition of exercise-induced shortening of bleeding time by fish oil in familial hypercholesterolemia (type IIa).
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1993;13(1):98-104.
1991: John-Bjarne Hansen; B Svensson; L Wilsgård; Bjarne Osterud
Serum enriched with n-3 polyunsaturated fatty acids inhibits procoagulant activity in endothelial cells.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1991;2(4):515-9.
1991: John-Bjarne Hansen; L Wilsgård; Bjarne Osterud
Biphasic changes in leukocytes induced by strenuous exercise.
European journal of applied physiology and occupational physiology 1991;62(3):157-61.
1990: John-Bjarne Hansen; L Wilsgård; Jan Ole Olsen; Bjarne Osterud
Formation and persistence of procoagulant and fibrinolytic activities in circulation after strenuous physical exercise.
Thrombosis and haemostasis 1990;64(3):385-9.
1990: John-Bjarne Hansen; Jan Ole Olsen; Bjarne Osterud
Physical exercise enhances plasma levels of extrinsic pathway inhibitor (EPI).
Thrombosis and haemostasis 1990;64(1):124-6.
1990: L N Berge; John-Bjarne Hansen; B Svensson; V Lyngmo; Arne Nordøy
Female sex hormones and platelet/endothelial cell interactions.
Haemostasis 1990;20(6):313-20.
1989: John-Bjarne Hansen; L Wilsgård; Jan Ole Olsen; B Svensson; Bjarne Osterud
The effect of lipopolysaccharides (LPS) on generation of thromboxane A2 and thromboplastin activity in whole blood of males, females and females on oral contraceptives.
Thrombosis and haemostasis 1989;61(3):493-6.
1989: Bjarne Osterud; John-Bjarne Hansen
Fatty acids, platelets and monocytes. Something to do with atherogenesis.
Annals of medicine 1989;21(1):47-51.
1989: John-Bjarne Hansen; Jan Ole Olsen; L Wilsgård; Bjarne Osterud
Effects of dietary supplementation with cod liver oil on monocyte thromboplastin synthesis, coagulation and fibrinolysis.
Journal of internal medicine. Supplement 1989;731():133-9.
1989: C Solberg; John-Bjarne Hansen; C Little
Centrifugation of very freshly donated blood may yield platelets unstable to storage in the new generation of containers.
Vox sanguinis 1989;56(1):25-31.